bk cytotoxic t lymphocytes
Cell therapyexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2020 (NCT04197596)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, passive
Immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05042076 | Phase 1 | Nov 30, 2021 | University of Wisconsin |
| NCT04197596 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2020 | Medical College of Wisconsin, New York Medical College, Ohio State University, University of Pennsylvania |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical College of Wisconsin | Academic/Hospital | 1 | 0 | 1 | 2020 |
| New York Medical College | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Ohio State University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Wisconsin | Academic/Hospital | 1 | 1 | 1 | 2021 |
5 organizations
Page 1 / 1